| Reference |
|---|
Brinkmann C, Jensen L, Dagnæs-Hansen F, Holm I, Endo Y, Fujita T, et al. Mitochondria and the lectin pathway of complement. J Biol Chem. 2013;288:8016-27 pubmed publisher |
Brady A, Calix J, Yu J, Geno K, Cutter G, Nahm M. Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation. J Infect Dis. 2014;210:1155-65 pubmed publisher |
Krarup A, Sørensen U, Matsushita M, Jensenius J, Thiel S. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun. 2005;73:1052-60 pubmed |
Matsushita M, Kilpatrick D, Shiraki H, Liu Y, Tateishi K, Tsujimura M, et al. Purification, measurement of concentration, and functional complement assay of human ficolins. Methods Mol Biol. 2014;1100:141-59 pubmed publisher |
Degn S, Hansen A, Steffensen R, Jacobsen C, Jensenius J, Thiel S. MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation. J Immunol. 2009;183:7371-8 pubmed publisher |
Dehus O, Pfitzenmaier M, Stuebs G, Fischer N, Schwaeble W, Morath S, et al. Growth temperature-dependent expression of structural variants of Listeria monocytogenes lipoteichoic acid. Immunobiology. 2011;216:24-31 pubmed publisher |
Fust G, Munthe-Fog L, Illes Z, Széplaki G, Molnar T, Pusch G, et al. Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke. J Neuroinflammation. 2011;8:185 pubmed publisher |
Brady A, Spencer B, Falsey A, Nahm M, Litwin V. Blood collection tubes influence serum ficolin-1 and ficolin-2 levels. Clin Vaccine Immunol. 2014;21:51-5 pubmed publisher |
Hu Y, Luo F, Fu J, Chen T, Wu S, Zhou Y, et al. Early increased ficolin-2 concentrations are associated with severity of liver inflammation and efficacy of anti-viral therapy in chronic hepatitis C patients. Scand J Immunol. 2013;77:144-50 pubmed publisher |
Wittenborn T, Thiel S, Jensen L, Nielsen H, Jensenius J. Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun. 2010;2:167-80 pubmed publisher |
Zacho R, Jensen L, Terp R, Jensenius J, Thiel S. Studies of the pattern recognition molecule H-ficolin: specificity and purification. J Biol Chem. 2012;287:8071-81 pubmed publisher |
Liu J, Ali M, Shi Y, Zhao Y, Luo F, Yu J, et al. Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cell Mol Immunol. 2009;6:235-44 pubmed publisher |
Fujieda M, Aoyagi Y, Matsubara K, Takeuchi Y, Fujimaki W, Matsushita M, et al. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci. Infect Immun. 2012;80:2053-60 pubmed publisher |
Pan Q, Chen H, Wang F, Jeza V, Hou W, Zhao Y, et al. L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo. J Innate Immun. 2012;4:312-24 pubmed publisher |
Aoyagi Y, Adderson E, Rubens C, Bohnsack J, Min J, Matsushita M, et al. L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway. Infect Immun. 2008;76:179-88 pubmed |
Luo F, Sun X, Wang Y, Wang Q, Wu Y, Pan Q, et al. Ficolin-2 defends against virulent Mycobacteria tuberculosis infection in vivo, and its insufficiency is associated with infection in humans. PLoS ONE. 2013;8:e73859 pubmed publisher |
Hamad I, Christy Hunter A, Rutt K, Liu Z, Dai H, Moein Moghimi S. Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. Mol Immunol. 2008;45:3797-803 pubmed publisher |
